Birmingham, ALNCT07475377Now EnrollingIRB Ready

Multiple Sclerosis Clinical Trial in Birmingham, AL

Access cutting-edge multiple sclerosis treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.

Sponsored by University of Alabama at Birmingham

Quick Self-Assessment

See if you qualify for this Birmingham location

Preparing your pre-screening questions…

Expert Care in Birmingham

Access multiple sclerosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related multiple sclerosis treatment provided free

Apply for This Birmingham Location

Check if you qualify for this multiple sclerosis clinical trial in Birmingham, AL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Birmingham

    Convenient for AL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Birmingham site if eligible
  4. 4Begin participation

About This Multiple Sclerosis Study in Birmingham

The goal of this clinical trial is to learn if the time an individual eats each day impacts neurological health in people with multiple sclerosis. The main questions the investigators are asking are: 1. Does meal timing affect biomarkers of neuronal health (neurofilament light chain \[NfL\] and BDNF) and inflammation (IL-6, IL-17, TNF-ɑ) in adults with MS. 2. Does meal timing affect expression of circadian clock genes and genes associated with autophagy in adults with MS. Participants will be instructed to start and stop eating at specific times each day based on their group assignment and their personal schedule. They will respond to prompts sent to them on their smartphone to record the times they start and stop eating each day. As a secondary goal, the study will also explore the feasibility of including translocator protein (TSPO)-PET imaging of neuroinflammation in future clinical trials of TRE in people with MS. To accomplish this, imaging will be completed in a subset of 8 participants at the beginning and end of the study.

Sponsor: University of Alabama at Birmingham

Who Can Participate

Inclusion Criteria

Diagnosed with relapsing remitting or secondary progressive multiple sclerosis (RRMS or SPMS)
If on disease modifying therapy (DMTs), stable for 6 months
If not on DMTs, no DMT usage within previous 6 months
BMI 18.5-50 kg/m2
Access to a smartphone
Responsible for personal eating schedule or able to have input into schedule

Exclusion Criteria

Relapse within previous 30 days
Actively engaged in a weight loss program or unwilling to follow assigned eating schedule
Current use of GLP-1 or use within previous 3 months
Regularly fasts \> 12 hours/day
Employed in night shift or rotating shift work
Unable to walk 25 feet with or without assistive device (EDSS \> 6.5).
Current use of insulin or sulfonylurea agents
Pregnant or breastfeeding
Currently enrolled in another trial that would confound results (e.g., exercise studies or other diet studies)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Birmingham?

Yes, this clinical trial (NCT07475377) has an active research site in Birmingham, AL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Multiple Sclerosis Treatment Options in Birmingham, AL

If you're searching for multiple sclerosis treatment options in Birmingham, AL, this clinical trial (NCT07475377) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all multiple sclerosis clinical trials near you to find additional studies recruiting in your area.

More Multiple Sclerosis Trials in Birmingham, AL

See all multiple sclerosis clinical trials recruiting in Birmingham — not just this study.

Browse Multiple Sclerosis Trials in Birmingham →

Browse More Trials by Condition

Ready to Join in Birmingham?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Birmingham, AL